Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

NCT04764500 ACTIVE_NOT_RECRUITING

This study is to identify and isolate well-defined microbials (non-ESBL E. coli) in an observational setting exploring natural gastrointestinal decolonization of humans colonized with ESBL E. coli.

Details

Lead sponsor	University Hospital, Basel, Switzerland
Status	ACTIVE_NOT_RECRUITING
Enrolment	39
Start date	2019-06-13
Completion	2025-12

Conditions

• Extended Spectrum Beta Lactamases (ESBL) E. Coli

Interventions

• examination of stool sample
• patient questionnaire
• examination of blood sample

Primary outcomes

• proportion of patients being "naturally" decolonized from ESBL E. coli — 18 months
  proportion of patients being "naturally" decolonized from ESBL E. coli at the end of the study period at 18 months

Countries

Switzerland